Investor Relations

Announcements and Others

Date Year  
2020.09.17 Proxy Form for the extraordinary general meeting to be held on Monday, 12 October 2020 at 2:30 p.m. (the "Meeting")
2020.09.17 NOTICE OF EXTRAORDINARY GENERAL MEETING
2020.09.11 CLARIFICATION ANNOUNCEMENT IN RELATION TO (1) PROPOSED CHANGE OF DOMICILE; (2) PROPOSED ADOPTION OF MEMORANDUM OF CONTINUANCE AND NEW BYE-LAWS; (3) PROPOSED REDUCTION OF SHARE PREMIUM ACCOUNT; (4) PROPOSED CAPITAL REORGANISATION; AND (5) PROPOSED CHANGE IN BOARD LOT SIZE
2020.09.11 Proxy Form for the extraordinary general meeting to be held on Tuesday, 29 September 2020 at 2:30 p.m. (the "Meeting")
2020.09.11 NOTICE OF EXTRAORDINARY GENERAL MEETING
2020.09.08 FURTHER DELAY IN DESPATCH OF CIRCULAR
2020.09.04 COMPANY INFORMATION SHEET
2020.09.04 CHANGE OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG
2020.09.04 CHANGE OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG
2020.09.02 Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 August 2020
2020.09.01 DELAY IN DESPATCH OF CIRCULAR
2020.08.31 POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 31 AUGUST 2020
2020.08.28 SUBSCRIPTION AND SETTLEMENT AGREEMENTS - ISSUE OF SHARES UNDER GENERAL MANDATE
2020.08.28 (1) PROPOSED CHANGE OF DOMICILE; (2) PROPOSED ADOPTION OF MEMORANDUM OF CONTINUANCE AND NEW BYE-LAWS; (3) PROPOSED REDUCTION OF SHARE PREMIUM ACCOUNT; (4) PROPOSED CAPITAL REORGANISATION; AND (5) PROPOSED CHANGE IN BOARD LOT SIZE
2020.08.11 MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN (I) CHINA REGENERATIVE MEDICINE TISSUE ENGINEERING LIMITED AND (II) CHINA REGENERATIVE HOSPITAL INVESTMENT MANAGEMENT LIMITED
2020.08.05 SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL RESULTS ANNOUNCEMENT AND THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2019
2020.08.05 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2020
2020.07.31 INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020
2020.07.31 NOTICE OF ANNUAL GENERAL MEETING
2020.07.31 Proxy Form for the annual general meeting to be held on Monday, 31 August 2020 at 2:30 p.m. (the "Meeting")
2020.07.27 COMPANY INFORMATION SHEET
2020.07.27 NEXT DAY DISCLOSURE RETURN
2020.07.22 COMPANY INFORMATION SHEET
2020.07.22 NEXT DAY DISCLOSURE RETURN
2020.07.20 NOTICE OF BOARD MEETING
2020.07.09 LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
2020.07.09 COMPANY INFORMATION SHEET
2020.07.09 CHANGE OF (1) EXECUTIVE DIRECTOR; (2) AUTHORIZED REPRESENTATIVE AND COMPLIANCE OFFICER; (3) CHIEF EXECUTIVE OFFICER
2020.07.03 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2020
2020.07.02 SUPPLEMENTAL ANNOUNCEMENT - (I) MATERIAL DIFFERENCES BETWEEN THE FINANCIAL INFORMATION IN THE UNAUDITED RESULTS ANNOUNCEMENT AND AUDITED RESULTS ANNOUNCEMENT; AND (II) DESPATCH OF 2019 ANNUAL REPORT
2020.07.02 ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2019
2020.07.01 SUPPLEMENTAL ANNOUNCEMENT - (I) MATERIAL DIFFERENCES BETWEEN THE FINANCIAL INFORMATION IN THE UNAUDITED RESULTS ANNOUNCEMENT AND AUDITED RESULTS ANNOUNCEMENT; AND (II) DESPATCH OF 2019 ANNUAL REPORT
2020.07.01 ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2019
2020.06.12 DELAY IN PUBLICATION OF AUDITED RESULTS ANNOUNCEMENT AND DESPATCH OF ANNUAL REPORT; DELAY IN AGM; AND NOTICE OF DATE OF BOARD MEETING
2020.06.01 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 May 2020
2020.05.29 COMPLETION OF VERY SUBSTANTIAL DISPOSAL / FURTHER SALE OF INTEREST IN A FUND
2020.05.22 COMPANY INFORMATION SHEET
2020.05.22 NEXT DAY DISCLOSURE RETURN
2020.05.20 APPOINTMENT OF EXECUTIVE DIRECTOR
2020.05.20 LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
2020.05.20 COMPANY INFORMATION SHEET
2020.05.19 CLARIFICATION ANNOUNCEMENT RELATING TO COMPLETION OF PLACING OF NEW SHARES UNDER SPECIFIC MANDATE
2020.05.19 COMPANY INFORMATION SHEET
2020.05.15 NEXT DAY DISCLOSURE RETURN
2020.05.15 COMPANY INFORMATION SHEET
2020.05.15 COMPLETION OF PLACING OF NEW SHARES UNDER SPECIFIC MANDATE
2020.05.15 FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2020
2020.05.08 Delay in Publication of Audited Annual Results Announcements and Annual Report/ Change of Date of Board Meeting
2020.05.07 POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 7 MAY 2020
2020.05.06 NOTICE OF BOARD MEETING
2020.05.04 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2020
2020.04.24 NOTICE OF BOARD MEETING PUBLICATION OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019 DESPATCH OF ANNUAL REPORT
2020.04.21 COMPLETION OF CONNECTED TRANSACTION - ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE
2020.04.20 Proxy Form for the Extraordinary General Meeting to be held on Thursday, 7 May 2020 at 2:30 p.m. (the "EGM")
2020.04.20 NOTICE OF EXTRAORDINARY GENERAL MEETING
2020.04.15 Announcements and Notices - POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 15 APRIL 2020
2020.04.09 FURTHER DELAY IN DESPATCH OF CIRCULAR
2020.04.08 ARRANGEMENT OF THE EXTRAORDINARY GENERAL MEETING
2020.04.02 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2020
2020.03.31 DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2019 AND DESPATCH OF 2019 ANNUAL REPORT
2020.03.31 ANNOUNCEMENT UNAUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
2020.03.27 DELAY IN DESPATCH OF CIRCULAR
2020.03.27 NOTICE OF EXTRAORDINARY GENERAL MEETING
2020.03.27 Proxy Form for the Extraordinary General Meeting to be held on Wednesday, 15 April 2020 at 2:30 p.m. (the "EGM")
2020.03.23 DELAY IN DESPATCH OF CIRCULAR
2020.03.18 (1) DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2019; AND (2) NOTICE OF BOARD MEETING
2020.03.13 DELAY IN DESPATCH OF CIRCULAR
2020.03.03 (I) PLACING OF NEW SHARES UNDER SPECIFIC MANDATE; AND (II) ISSUE OF CONVERTIBLE BONDS
2020.03.02 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2020
2020.02.21 VERY SUBSTANTIAL DISPOSAL FURTHER SALE OF INTEREST IN A FUND
2020.02.20 SUPPLEMENTAL ANNOUNCEMENT TO THE TERMINATION OF OPEN OFFER
2020.02.19 TERMINATION OF OPEN OFFER
2020.02.03 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2020
2020.01.30 CHANGE OF NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR
2020.01.30 LIST OF DIRECTORS AND THEIR ROLE AND FUNCTIONS
2020.01.30 COMPANY INFORMATION SHEET
2020.01.29 VOLUNTARY ANNOUNCEMENT POSSIBLE FURTHER SALE OF INTEREST IN A FUND
2020.01.22 POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 22 JANUARY 2020
2020.01.20 SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION RELATING TO THE SALE OF INTEREST IN A FUND
2020.01.06 DISCLOSEABLE TRANSACTION SALE OF INTEREST IN A FUND
2020.01.03 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2019

IR Contact

China Regenerative Medicine International Limited

A:

Rooms 3006–10, 30/F., China Resources Building, 26 Harbour Road, Wanchai, Hong Kong

E: info@crmi.hk|

T: +852 3966 8388 |

F: +852 2802 0026